146 related articles for article (PubMed ID: 36007997)
21. RNA delivery biomaterials for the treatment of genetic and rare diseases.
Zhao W; Hou X; Vick OG; Dong Y
Biomaterials; 2019 Oct; 217():119291. PubMed ID: 31255978
[TBL] [Abstract][Full Text] [Related]
22. National Rare Diseases Registry System of China and Related Cohort Studies: Vision and Roadmap.
Feng S; Liu S; Zhu C; Gong M; Zhu Y; Zhang S
Hum Gene Ther; 2018 Feb; 29(2):128-135. PubMed ID: 29284292
[TBL] [Abstract][Full Text] [Related]
23. Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases' community.
Rajasimha HK; Shirol PB; Ramamoorthy P; Hegde M; Barde S; Chandru V; Ravinandan ME; Ramchandran R; Haldar K; Lin JC; Babar IA; Girisha KM; Srinivasan S; Navaneetham D; Battu R; Devarakonda R; Kini U; Vijayachandra K; Verma IC
Genet Res (Camb); 2014 Aug; 96():e009. PubMed ID: 25579084
[TBL] [Abstract][Full Text] [Related]
24. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
25. The discovery of medicines for rare diseases.
Swinney DC; Xia S
Future Med Chem; 2014 Jun; 6(9):987-1002. PubMed ID: 25068983
[TBL] [Abstract][Full Text] [Related]
26. Health technologies for rare diseases: does conventional HTA still apply?
Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):315-7. PubMed ID: 24702042
[TBL] [Abstract][Full Text] [Related]
27. Phenotype-genotype comorbidity analysis of patients with rare disorders provides insight into their pathological and molecular bases.
Díaz-Santiago E; Jabato FM; Rojano E; Seoane P; Pazos F; Perkins JR; Ranea JAG
PLoS Genet; 2020 Oct; 16(10):e1009054. PubMed ID: 33001999
[TBL] [Abstract][Full Text] [Related]
28. From gene to treatment: supporting rare disease translational research through model systems.
Hmeljak J; Justice MJ
Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30819728
[TBL] [Abstract][Full Text] [Related]
29. Rare-disease genetics in the era of next-generation sequencing: discovery to translation.
Boycott KM; Vanstone MR; Bulman DE; MacKenzie AE
Nat Rev Genet; 2013 Oct; 14(10):681-91. PubMed ID: 23999272
[TBL] [Abstract][Full Text] [Related]
30. Innovations in Therapy Development for Rare Diseases Through the Rare Disease Cures Accelerator-Data and Analytics Platform.
Larkindale J; Betourne A; Borens A; Boulanger V; Theurer Crider V; Gavin P; Burton J; Liwski R; Romero K; Walls R; Barrett JS
Ther Innov Regul Sci; 2022 Sep; 56(5):768-776. PubMed ID: 35668316
[TBL] [Abstract][Full Text] [Related]
31. Meeting the needs of patients with ultrarare diseases.
Crooke ST
Trends Mol Med; 2022 Feb; 28(2):87-96. PubMed ID: 35000835
[TBL] [Abstract][Full Text] [Related]
32. The Rare Knowledge Mining Methodological Framework for the Development of Practice Guidelines and Knowledge Translation Tools for Rare Diseases.
Gagnon C; Fortin J; Lamontagne ME; Plourde A
J Neuromuscul Dis; 2021; 8(6):1017-1029. PubMed ID: 34250944
[TBL] [Abstract][Full Text] [Related]
33. Drugs for rare disorders.
Cremers S; Aronson JK
Br J Clin Pharmacol; 2017 Aug; 83(8):1607-1613. PubMed ID: 28653488
[TBL] [Abstract][Full Text] [Related]
34. A generalizable pre-clinical research approach for orphan disease therapy.
Beaulieu CL; Samuels ME; Ekins S; McMaster CR; Edwards AM; Krainer AR; Hicks GG; Frey BJ; Boycott KM; Mackenzie AE
Orphanet J Rare Dis; 2012 Jun; 7():39. PubMed ID: 22704758
[TBL] [Abstract][Full Text] [Related]
35. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
36. [Application of Next-Generation Sequencing in Rare Renal Diseases].
Cai ZY; Zhao JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):484-490. PubMed ID: 35791948
[TBL] [Abstract][Full Text] [Related]
37. Are we prepared to deliver gene-targeted therapies for rare diseases?
Yu TW; Kingsmore SF; Green RC; MacKenzie T; Wasserstein M; Caggana M; Gold NB; Kennedy A; Kishnani PS; Might M; Brooks PJ; Morris JA; Parisi MA; Urv TK
Am J Med Genet C Semin Med Genet; 2023 Mar; 193(1):7-12. PubMed ID: 36691939
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
